Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 6, 2021
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
Thu, August 5, 2021
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
Anupam Rama Upgraded (SRPT) to Hold and Decreased Target to $87 on, Aug 5th, 2021
Anupam Rama of JP Morgan, Upgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $92 to $87 on, Aug 5th, 2021.
Anupam has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $93 on, Monday, April 19th, 2021
This is the rating of the analyst that currently disagrees with Anupam
- Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $110 on, Tuesday, June 15th, 2021
